Malaria Vaccine.
Abstract
The invention provides an antigenic protein consisting essentially of a merozoite polypeptide selected from the group consisting of an erythrocyte and merozoite binding protein derived form Plasmodium falciparum; and erythrocyte and merozoite binding protein derived from Plasmodium vivax; an erythrocyte and merozoite binding protein derived from Plasmodium ovalae; and an erythrocyte and merozoite binding protein derived from Plasmodium malariae in purified form. The invention also provides a composition for the vaccination of a human against malaria consisting essentially of an erthrocyte and merozoite binding antigenic protein and a carrier therefore, the concentration of antigenic protein being sufficient to provide an immune protection of a human against malaria.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 27, 1985
- Accession Number
- ADD011994
Entities
People
- Daniel E. Camus
Organizations
- United States Army